ADSL and infection: Nowadays, recombinant AMPs is promising alternatives to conventional antibiotics for the treatment of pathogens infections because of chemical synthesis is not suited for synthesis of large AMPs and is not scalable for large-scale production for clinical studies and commercial use (Cao et al., 2018; Wei et al., 2018; Kim et al., 2019; Meng et al., 2019).